IDEAYA Biosciences, Inc. Common Stock
Veridion Score
Composite trend over time
Why is IDYA moving today?
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for IDYA.
IDYA insider activity
IDEAYA Biosciences, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for IDYA.
IDYA contract awards, year to date.
Public federal awards linked to this ticker.
IDYA lobbying filings, year to date.
Registered lobbying filings matched to IDEAYA Biosciences, Inc. Common Stock.